Followers | 228 |
Posts | 14879 |
Boards Moderated | 1 |
Alias Born | 03/29/2014 |
Tuesday, April 19, 2022 9:14:24 PM
So were Linda Liau and Dr. Nghiemphu lying when they told me that?
Was I lying?
Here’s a link to the event:
https://www.eventbrite.com/e/ucla-brain-tumor-center-community-lecture-tickets-86420539159
And listed below is my post that I'd made while I was present at the event stating that she'd told me this.
The next day, I’d written another post indicating that I’d spoken with Dr. Nghiemphu and that she, too, had confirmed that the ATL-DC vaccine UCLA was using in their combo trial was indeed DCVax-L.
and...
About Dr. P. Leia Nghiemphu
https://www.uclahealth.org/providers/phioanh-nghiemphu
Adam writes that Northwest Bio doesn’t have the rights to ATL-DC. Of course, that’s a rather sloppy way of putting it, but let’s dive down on what he might have meant by that statement.
Does Adam mean NWBO doesn’t have the right to control the combo trial at UCLA?
Okay, he’d be right. It’s UCLA’s trial, not Northwest’s.
Does Adam mean NWBO doesn’t have the right to use the data to the combo trial at UCLA?
He’d be right about that, too. It’s UCLA’s data.
But if the ATL-DC vaccine for which the trademarked name is DCVax-L (which is what Adam's emails indicate to be the case) extends life for rGBM patients in combo with a checkpoint inhibitor, where would a patient go to obtain this ATL-DC vaccine for which the trademarked name is DCVax-L?
How would a doctor prescribe it?
Would they prescribe an ATL-DC vaccine and tell the patient to head on down to UCLA to have it made?
Of course not.
Does Adam mean that NWBO doesn’t have the manufacturing rights to the ATL-DC vaccine for which the trademarked name is DCVax-L?
Well, I doubt that. As it is obviously NWBO and not UCLA that will be filing for the manufacturing licenses with the regulators to manufacture the ATL-DC vaccine trademarked as DCVax-L.
And if the vaccine works in the combo trial, no matter what you call DCVax-L, that only helps Northwest, because the only place a patient will be able to get their vaccine manufactured will be from Northwest who will be (hopefully) licensed to sell it.
I hope this helps. — senti. :)
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM